Wave Life Sciences (WVE) Accumulated Depreciation & Amortization (2016 - 2025)
Wave Life Sciences (WVE) has disclosed Accumulated Depreciation & Amortization for 11 consecutive years, with $49.5 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 6.89% year-over-year to $49.5 million, compared with a TTM value of $49.5 million through Dec 2025, up 6.89%, and an annual FY2025 reading of $49.5 million, up 6.89% over the prior year.
- Accumulated Depreciation & Amortization was $49.5 million for Q4 2025 at Wave Life Sciences, up from $46.3 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $49.5 million in Q4 2025 and bottomed at $32.2 million in Q4 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $41.7 million, with a median of $42.7 million recorded in 2023.
- The sharpest move saw Accumulated Depreciation & Amortization rose 29.47% in 2021, then rose 6.89% in 2025.
- Year by year, Accumulated Depreciation & Amortization stood at $32.2 million in 2021, then rose by 17.42% to $37.8 million in 2022, then rose by 12.85% to $42.7 million in 2023, then grew by 8.48% to $46.3 million in 2024, then increased by 6.89% to $49.5 million in 2025.
- Business Quant data shows Accumulated Depreciation & Amortization for WVE at $49.5 million in Q4 2025, $46.3 million in Q4 2024, and $42.7 million in Q4 2023.